About: http://data.cimple.eu/news-article/c284aec0bca5f35ca960535d1499ae605b17fef7c085b8041eaad724

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/c284aec0bca5f35ca960535d1499ae605b17fef7c085b8041eaad724 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Tokyo stocks ended higher on Thursday, tracking rallies on Wall Street amid fresh hopes for greater supplies of coronavirus vaccines that may normalise the global economy. The benchmark Nikkei 225 index added 1.67 percent or 496.57 points at 30,168.27, while the broader Topix index gained 1.22 percent or 23.16 points to 1,926.23. Documents released by the US Food and Drug Administration on Wednesday showed the single-shot Johnson & Johnson vaccine is highly effective in preventing severe Covid-19, including newer variants. Wall Street shares bounced back as the news cheered investors. "Japanese shares are seen rallying supported by gains in the US market," said Toshiyuki Kanayama, senior analyst at Monex. The dollar fetched 105.89 yen in Asian trade, against 105.85 yen in New York late Wednesday. Rallies on Wall Street, where the Dow finished up 1.4 percent to close at 31,961.86, a new all-time high, kept Tokyo investors bullish. Nintendo rose 2.89 percent to 68,360 yen. SoftBank Group added 3.84 percent to 10,365. Toyota rose 1.61 percent to 8,018 yen. Sony jumped 2.16 percent to 11,570. Bargain hunting lifted the Nikkei particularly in the morning session, before the index became trapped in a narrow band in the afternoon trade, said Okasan Online Securities. "The market basically regained what it lost yesterday," the brokerage said, referring to a 1.61 percent loss of the Nikkei on Wednesday. In Tokyo, chipmaker Murata Manufacturing rose 3.00 percent to 9,579 yen. Takeda Pharmaceutical trimmed earlier gains and ended up 0.14 percent at 3,610 yen after it said it had started a clinical trial in Japan of the Novavax Covid-19 vaccine. Takeda also said it expects results from an ongoing Moderna trial in the first half of this year. Suzuki gave up 3.30 percent at 4,805 yen after it said its charismatic chairman Osamu Suzuki will retire after more than four decades at the helm of the Japanese carmaker. hih/sah/rbu
schema:headline	Tokyo shares rise on vaccine hopes, US gains
schema:mentions	Novavax Sony Toyota USA Gymnastics Clinical trial Nintendo Johnson & Johnson Hunting United States dollar Japan Race and ethnicity in the United States Census New York City Vaccine Severe acute respiratory syndrome coronavirus 2 Coronavirus disease 2019 Murata Manufacturing Gero, Gifu Takeda Pharmaceutical Company Suzuki SoftBank Group Japanese yen Nikkei 225 Tokyo Stock Exchange
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-02-25 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	48 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software